Key Record Dates
| ClinicalTrials.gov Identifier: | NCT06039202 |
|---|---|
| Brief Title: | Phase 2 Study of CA102N Combined With TAS-102 Compared to Bevacizumab Combined With TAS-102 in Subjects With Relapsed and/or Refractory Metastatic Colorectal Cancer |
| First Submitted : | September 1, 2023 |
| First Submitted that Met QC Criteria : | September 8, 2023 |
| First Posted : | September 15, 2023 |
| Last Update Submitted that Met QC Criteria : | September 8, 2023 |
| Last Update Posted : | September 15, 2023 |